Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Expenses (2016 - 2021)

Historic Operating Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to $3.1 million.

  • ENDRA Life Sciences' Operating Expenses rose 3625.0% to $3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $11.5 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $10.8 million for FY2024, which is 281.74% up from last year.
  • According to the latest figures from Q4 2021, ENDRA Life Sciences' Operating Expenses is $3.1 million, which was up 3625.0% from $2.7 million recorded in Q3 2021.
  • ENDRA Life Sciences' Operating Expenses' 5-year high stood at $3.3 million during Q3 2020, with a 5-year trough of $360697.0 in Q1 2017.
  • Its 5-year average for Operating Expenses is $2.4 million, with a median of $2.6 million in 2019.
  • In the last 5 years, ENDRA Life Sciences' Operating Expenses skyrocketed by 68841.58% in 2018 and then plummeted by 2799.16% in 2020.
  • Over the past 5 years, ENDRA Life Sciences' Operating Expenses (Quarter) stood at $2.3 million in 2017, then dropped by 12.93% to $2.0 million in 2018, then surged by 56.31% to $3.1 million in 2019, then dropped by 27.99% to $2.3 million in 2020, then skyrocketed by 36.25% to $3.1 million in 2021.
  • Its last three reported values are $3.1 million in Q4 2021, $2.7 million for Q3 2021, and $3.2 million during Q2 2021.